大伏在静脈本幹のエコーガイド下フォーム硬化療法の有用性について

大伏在静脈本幹硬化療法の高位結紮を併用する方法,高位結紮をしない方法の両者において,術後1年の経過を報告する.【方法】HL+法48例:高位結紮およびGSV根部を部分切除し,GSV断端から末梢側へ硬化剤を注入した.HL-法43例:下腿のGSV分枝から硬化剤を注入し,エコーでフォームをGSV本幹内,SFJまで誘導した.硬化剤は3%または1%POL:CO2=1 : 3,Tessari法で作製した.術後1,3,6,12カ月後に超音波検査にて経過を追った.【結果】大腿部の閉塞率はHL+法:6カ月後80.4%,12カ月後75.5%,HL-法:6カ月後63.4%,12カ月後52.8%であった.深部静脈血栓症...

Full description

Saved in:
Bibliographic Details
Published in静脈学 Vol. 23; no. 1; pp. 1 - 5
Main Authors 久米, 博子, 佐藤, 彰治, 加賀山, 知子, 藤田, 聡子, 岩井, 武尚
Format Journal Article
LanguageJapanese
Published 日本静脈学会 25.02.2012
Subjects
Online AccessGet full text
ISSN0915-7395
2186-5523
DOI10.7134/phlebol.23.1

Cover

Abstract 大伏在静脈本幹硬化療法の高位結紮を併用する方法,高位結紮をしない方法の両者において,術後1年の経過を報告する.【方法】HL+法48例:高位結紮およびGSV根部を部分切除し,GSV断端から末梢側へ硬化剤を注入した.HL-法43例:下腿のGSV分枝から硬化剤を注入し,エコーでフォームをGSV本幹内,SFJまで誘導した.硬化剤は3%または1%POL:CO2=1 : 3,Tessari法で作製した.術後1,3,6,12カ月後に超音波検査にて経過を追った.【結果】大腿部の閉塞率はHL+法:6カ月後80.4%,12カ月後75.5%,HL-法:6カ月後63.4%,12カ月後52.8%であった.深部静脈血栓症などの有害事象は認めなかった.【結語】フォーム硬化療法は大伏在静脈不全に対する治療として,安全に施行できる.HL-法はHL+法に比べ,閉塞率は劣るが,治療としての有用性が示唆された.
AbstractList 大伏在静脈本幹硬化療法の高位結紮を併用する方法,高位結紮をしない方法の両者において,術後1年の経過を報告する.【方法】HL+法48例:高位結紮およびGSV根部を部分切除し,GSV断端から末梢側へ硬化剤を注入した.HL-法43例:下腿のGSV分枝から硬化剤を注入し,エコーでフォームをGSV本幹内,SFJまで誘導した.硬化剤は3%または1%POL:CO2=1 : 3,Tessari法で作製した.術後1,3,6,12カ月後に超音波検査にて経過を追った.【結果】大腿部の閉塞率はHL+法:6カ月後80.4%,12カ月後75.5%,HL-法:6カ月後63.4%,12カ月後52.8%であった.深部静脈血栓症などの有害事象は認めなかった.【結語】フォーム硬化療法は大伏在静脈不全に対する治療として,安全に施行できる.HL-法はHL+法に比べ,閉塞率は劣るが,治療としての有用性が示唆された.
「要約」:大伏在静脈本幹硬化療法の高位結紮を併用する方法, 高位結紮をしない方法の両者において, 術後1年の経過を報告する. 【方法】HL+法48例:高位結紮およびGSV根部を部分切除し, GSV断端から末梢側へ硬化剤を注入した. HL-法43例:下腿のGSV分枝から硬化剤を注入し, エコーでフォームをGSV本幹内, SFJまで誘導した. 硬化剤は3%または1%POL:CO2=1:3, Tessari法で作製した. 術後1, 3, 6, 12カ月後に超音波検査にて経過を追った. 【結果】大腿部の閉塞率はHL+法:6カ月後80.4%, 12カ月後75.5%, HL-法:6カ月後63.4%, 12カ月後52.8%であった. 深部静脈血栓症などの有害事象は認めなかった. 【結語】フォーム硬化療法は大伏在静脈不全に対する治療として, 安全に施行できる. HL-法はHL+法に比べ, 閉塞率は劣るが, 治療としての有用性が示唆された.
Author 佐藤, 彰治
久米, 博子
藤田, 聡子
岩井, 武尚
加賀山, 知子
Author_xml – sequence: 1
  fullname: 久米, 博子
  organization: 慶友会つくば血管センター
– sequence: 1
  fullname: 佐藤, 彰治
  organization: 慶友会つくば血管センター
– sequence: 1
  fullname: 加賀山, 知子
  organization: 慶友会つくば血管センター
– sequence: 1
  fullname: 藤田, 聡子
  organization: 慶友会つくば血管センター
– sequence: 1
  fullname: 岩井, 武尚
  organization: 慶友会つくば血管センター
BookMark eNo9kMtKw0AUhgepYNXufI3UubadZSneQHCjSxkmycQmpElJdeHOpF1YFNyoIFRQKLZicdONgm8zvehbmBJxcf6fc-E78K-CXBAGCoANBItlROhms-4rM_SLmBTREshjVCkZjGGSA3nIETPKhLMVUGi1XBMyVKKIUZgHx9P-YPJ1M-0Nfx4fvjuXs95o-vmp43edDHUy1u0vnYx00tft7uTjSrfvdPK6GLaf5s-j6fX9_CGZje_S-1mvO78dzi4GOn7TcV_HHR2_rINlR_otVfjzNXC0vXVY2zX2D3b2atV9w8MII4Na3LQJ446DeIU4uERMuwSRY1fK2LQlhlA6ZU6Z5NihNrOphanDoVK2ZVECOVkDOxm3oWzXkn4Y-G6ghBeeRUH6V6iQel7YrAsMERYQYgJRaovKJM2pQjFFKamakbzWqTxRohm5DRmdCxmdupaf9lnKAhOBMkH_O6suI-FJ8guSEJl8
ContentType Journal Article
Copyright 2012 日本静脈学会
Copyright_xml – notice: 2012 日本静脈学会
CorporateAuthor 慶友会つくば血管センター
CorporateAuthor_xml – name: 慶友会つくば血管センター
DOI 10.7134/phlebol.23.1
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
EISSN 2186-5523
EndPage 5
ExternalDocumentID eo4jjoph_2012_002301_001_0001_00052384241
article_phlebol_23_1_23_1_1_article_char_ja
GroupedDBID ABJNI
ALMA_UNASSIGNED_HOLDINGS
GROUPED_DOAJ
JSF
MOJWN
RJT
ID FETCH-LOGICAL-j2121-4c9bd359ff1983f263bd601fd872bda200af7945a92f4d5d4c24f90eedcc43093
ISSN 0915-7395
IngestDate Thu Jul 10 16:10:21 EDT 2025
Wed Sep 03 06:30:48 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language Japanese
License https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2121-4c9bd359ff1983f263bd601fd872bda200af7945a92f4d5d4c24f90eedcc43093
OpenAccessLink https://www.jstage.jst.go.jp/article/phlebol/23/1/23_1_1/_article/-char/ja
PageCount 5
ParticipantIDs medicalonline_journals_eo4jjoph_2012_002301_001_0001_00052384241
jstage_primary_article_phlebol_23_1_23_1_1_article_char_ja
PublicationCentury 2000
PublicationDate 2012/02/25
PublicationDateYYYYMMDD 2012-02-25
PublicationDate_xml – month: 02
  year: 2012
  text: 2012/02/25
  day: 25
PublicationDecade 2010
PublicationTitle 静脈学
PublicationTitleAlternate 静脈学
PublicationYear 2012
Publisher 日本静脈学会
Publisher_xml – name: 日本静脈学会
References 12)Blaise S, Bosson JL, Diamand JM: Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up. Eur J Vasc Endovasc Surg 2010; 39: 779-786
4)佐藤彰治,加賀山知子,久米博子,他:小伏在静脈瘤に対するエコーガイド下フォーム硬化療法と短期成績.静脈学 2008; 19: 247-254
1)Rabe E, Otto J, Schliephake D, et al: Efficacy and safety of great saphenous vein sclerotherapy using standardized polidocanol foam (ESAF): a randomized controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008; 35: 238-245
2)Ouvry P, Allaert FA, Desnos P, et al: Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up. Eur J Vasc Endovasc Surg 2008; 36: 366-370
8)O'Hare JL, Parkin D, Vandenbroeck CP, et al: Mid term results of ultrasound guided foam sclerotherapy for complicated and uncomplicated varicose veins. Eur J Vasc Endovasc Surg 2008; 36: 109-113
7)Figueiredo M, Araújo S, Barros N Jr, et al: Results of surgical treatment compared with ultrasound-guided foam sclerotherapy in patients with varicose veins: a prospective randomised study. Eur J Vasc Endovasc Surg 2009; 38:758-763
3)Myers KA, Roberts S: Evaluation of published reports of foam sclerotherapy: what do we know conclusively? Phlebology 2009; 24: 275-280
10)Morrison N, Neuhardt DL, Rogers CR, et al: Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008; 47: 830-836
13)Bountouroglou DG, Azzam M, Kakkos SK, et al: Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial. Eur J Vasc Endovasc Surg 2006; 31: 93-100
5)Abela R, Liamis A, Prionidis I, et al: Reverse foam sclerotherapy of the great saphenous vein with sapheno-femoral ligation compared to standard and invagination stripping: a prospective clinical series. Eur J Vasc Endovasc Surg 2008; 36: 485-490
6)日本静脈学会監修:フォーム硬化療法の手引(第2回ヨーロッパコンセンサスミーティング2006翻訳版).日本静脈学会,2010
9)Hertzman PA, Owens R: Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy. Phlebology 2007; 22: 34-39
11)Wright D, Gobin JP, Bradbury AW, et al: Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006; 21: 180-190
References_xml – reference: 1)Rabe E, Otto J, Schliephake D, et al: Efficacy and safety of great saphenous vein sclerotherapy using standardized polidocanol foam (ESAF): a randomized controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008; 35: 238-245
– reference: 3)Myers KA, Roberts S: Evaluation of published reports of foam sclerotherapy: what do we know conclusively? Phlebology 2009; 24: 275-280
– reference: 6)日本静脈学会監修:フォーム硬化療法の手引(第2回ヨーロッパコンセンサスミーティング2006翻訳版).日本静脈学会,2010
– reference: 7)Figueiredo M, Araújo S, Barros N Jr, et al: Results of surgical treatment compared with ultrasound-guided foam sclerotherapy in patients with varicose veins: a prospective randomised study. Eur J Vasc Endovasc Surg 2009; 38:758-763
– reference: 9)Hertzman PA, Owens R: Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy. Phlebology 2007; 22: 34-39
– reference: 13)Bountouroglou DG, Azzam M, Kakkos SK, et al: Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial. Eur J Vasc Endovasc Surg 2006; 31: 93-100
– reference: 4)佐藤彰治,加賀山知子,久米博子,他:小伏在静脈瘤に対するエコーガイド下フォーム硬化療法と短期成績.静脈学 2008; 19: 247-254
– reference: 11)Wright D, Gobin JP, Bradbury AW, et al: Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006; 21: 180-190
– reference: 12)Blaise S, Bosson JL, Diamand JM: Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up. Eur J Vasc Endovasc Surg 2010; 39: 779-786
– reference: 8)O'Hare JL, Parkin D, Vandenbroeck CP, et al: Mid term results of ultrasound guided foam sclerotherapy for complicated and uncomplicated varicose veins. Eur J Vasc Endovasc Surg 2008; 36: 109-113
– reference: 5)Abela R, Liamis A, Prionidis I, et al: Reverse foam sclerotherapy of the great saphenous vein with sapheno-femoral ligation compared to standard and invagination stripping: a prospective clinical series. Eur J Vasc Endovasc Surg 2008; 36: 485-490
– reference: 10)Morrison N, Neuhardt DL, Rogers CR, et al: Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008; 47: 830-836
– reference: 2)Ouvry P, Allaert FA, Desnos P, et al: Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up. Eur J Vasc Endovasc Surg 2008; 36: 366-370
SSID ssib051641540
ssj0002909513
ssib058493114
ssib002004226
Score 1.8914343
Snippet 大伏在静脈本幹硬化療法の高位結紮を併用する方法,高位結紮をしない方法の両者において,術後1年の経過を報告する.【方法】HL+法48例:高位結紮およびGSV根部を部分切...
「要約」:大伏在静脈本幹硬化療法の高位結紮を併用する方法, 高位結紮をしない方法の両者において, 術後1年の経過を報告する. 【方法】HL+法48例:高位結紮およびGSV根部を部分...
SourceID medicalonline
jstage
SourceType Publisher
StartPage 1
SubjectTerms エコーガイド
フォーム硬化療法
ポリドカノール
伏在型静脈瘤
Title 大伏在静脈本幹のエコーガイド下フォーム硬化療法の有用性について
URI https://www.jstage.jst.go.jp/article/phlebol/23/1/23_1_1/_article/-char/ja
http://mol.medicalonline.jp/library/journal/download?GoodsID=eo4jjoph/2012/002301/001&name=0001-0005j
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 静脈学, 2012/02/25, Vol.23(1), pp.1-5
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2186-5523
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib051641540
  issn: 0915-7395
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Na9RANNR6EUQUFesXPTjH1J3MJJnxZLJNKYKeWuhFQj42lKW2pbYXD-Lu9mBR8GKFQgWFYisWL71Y6L9Jd1f_he9NJvsBK1iFEN6-efPmzZuZnfeS9yaGcY-KWpSBpWqmktVMnqaRGTGXw1wWNZ6A42xVMFH48RNndp4_WrAXxs51B6KWNtbjqeTFyLySfxlVwMG4YpbsGUa2xxQQAMP4wh1GGO5_NcYksInHieeSgBO_SsQMYmSVeIIEkshpIiUJBBFgMALGUUVVpPElXgEDQ5J4gQIsVUsBPlMAQ566qAdwXSSkahSY-xoj7ZJGDldnxKuQwCUe1a2LKpEOYkA8oAfB_F71Qh4lKjYBNFwJ5mBMBva0oPFLgGtAlIDnDBrco_QASpsuyWCuqX6AIDa25lOUBeadkhMqeppeVoboEYEspYsiaHrA-hXVHdCh36cHTp7SgUDm0A-kpXipitDHGeLZIxoq-RdqAN6KXqhu0mF6_eQGQ2Ass8jyVmtN6dJV7Hvj_0eV6HkkvcEnuNQ28T1rsZUrHH5hzLTtIoW73OD0r8GFXOxWdMDssUftp5hojB-BXlyCzW9pymJTtG839KI59fwPNVlosZAWNxqWZZhDGNbBkTlv4frHGNuXQd9OVEfR9exiG3x4MO17GwkYyZJR_bofTSxLomegokdKJRRJLSjw_UFxwbCsg5uF52dcfFa8-iyOoBmwIucuG5e0-zfpFfJeMcbq0VXjaXtv__TkXXv34NfHnZ-brzu7h-3j47zxPW8e5M2jvHWSNw_z5l7e2jr98SZvbefNr4hsfep-Pmy__dDdaXaOtoG-s7vVfX_QebWfN77ljb28sZk3vlwz5meCueqsqT97YtbBjqQmT2ScMltmGZWCZZbD4tSp0CwVrhWnEegqymAXtSNpZTy1U55YPJMVMHaThGNgw3VjfHlluXbDmOQsEsAtTpOIcYfG0qIuSxPqOJGMI-pMGA8K7YSrxdk24RnGcsJ4OKTRUP8zPg9rK7xeX1ldDHHWh-oxB8XgWRXpEqroAiY4-A43_6f9W8aF_qq6bYyvr23U7oCHsB7fVbPrN0ST6l4
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%A4%A7%E4%BC%8F%E5%9C%A8%E9%9D%99%E8%84%88%E6%9C%AC%E5%B9%B9%E3%81%AE%E3%82%A8%E3%82%B3%E3%83%BC%E3%82%AC%E3%82%A4%E3%83%89%E4%B8%8B%E3%83%95%E3%82%A9%E3%83%BC%E3%83%A0%E7%A1%AC%E5%8C%96%E7%99%82%E6%B3%95%E3%81%AE%E6%9C%89%E7%94%A8%E6%80%A7%E3%81%AB%E3%81%A4%E3%81%84%E3%81%A6&rft.jtitle=%E9%9D%99%E8%84%88%E5%AD%A6&rft.au=%E4%B9%85%E7%B1%B3%2C+%E5%8D%9A%E5%AD%90&rft.au=%E4%BD%90%E8%97%A4%2C+%E5%BD%B0%E6%B2%BB&rft.au=%E5%8A%A0%E8%B3%80%E5%B1%B1%2C+%E7%9F%A5%E5%AD%90&rft.au=%E8%97%A4%E7%94%B0%2C+%E8%81%A1%E5%AD%90&rft.date=2012-02-25&rft.pub=%E6%97%A5%E6%9C%AC%E9%9D%99%E8%84%88%E5%AD%A6%E4%BC%9A&rft.issn=0915-7395&rft.eissn=2186-5523&rft.volume=23&rft.issue=1&rft.spage=1&rft.epage=5&rft_id=info:doi/10.7134%2Fphlebol.23.1&rft.externalDocID=article_phlebol_23_1_23_1_1_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0915-7395&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0915-7395&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0915-7395&client=summon